DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

Novartis (NYSE: NVS)

94.06 0.16 (0.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $94.06 0.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.41
Previous Close $93.90
Daily Range $93.57 - $94.46
52-Week Range $72.77 - $95.50
Market Cap $228.2B
P/E Ratio 25.38
Dividend (Yield) $2.72 (2.5%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,263,999
Average Daily Volume 1,209,508
Current FY EPS $5.19

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

Google Invests in Smart Spoons for Parkinson's Patients

Google just acquired Lift Labs, a maker of tremor-canceling spoons for Parkinson’s patients. How does this fit into the tech giant’s other healthcare initiatives?

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter

Unilife: A Medical Device Company Poised For Major Upside On New Revenue Streams

European ADRs Lower Despite Banking Gains

Actavis Is The Best Bet In The Drug Sector

Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog

ProQR Therapeutics: Competition, Distance From Clinical Trials Leads Us To Hold Off

Eli Lilly Will Soon Emerge As A Star

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $94.06 (0.17%)
Current stock: NVS
JNJ $107.88 (-0.10%)
Current stock: JNJ
MRK $60.58 (0.15%)
Current stock: MRK
GSK $47.32 (-0.13%)
Current stock: GSK